Clinical Trials Browser

NIH × Syndrome × Clear all

NCT00068146 2018-07-05

Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma

Lymphadenopathy, Lymphoma, Lymphoproliferative Disorders, Syndrome, Genetic Diseases, Inborn